| TREATMENT INDICATIONS FOR ANTIDEPRESSANTS PRESCRIBED IN PRIMARY CARE IN FRANCE, 2006-2015 |
| Author(s): Schwalm MS, Miotti H, Hellard C, Nounit L, Trehony J, Jouaville SL |
| Affiliations(s): IMS HEALTH, Boulogne Billancourt, France |
| Publication(s): ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
| Document Type(s): Abstract |
| Countries: France |
C:
Y: |
Clinical practice, Mental health
2016 |
|
L:
A: |
English
Clinical setting: Primary care, Retrospective database analysis |
|
 |
| |
| |
| BIOLOGICS USE IN CROHN’S DISEASE IN France |
| Author(s): 1-Morand F, 2-Gaudry JL, 3-Willemin L, 4-Lee XY, 5-Lelli F |
| Affiliations(s): 1- IMS Health Paris France, 2- IMS Health Boulogne-Billancourt France, 3-Janssen-Cilag Issy-les-Moulineaux France, 4-Janssen-Cilag Birkerod Denmark, Janssen-Cilag Colgno Monzese Italy |
| Publication(s): 19th ISPOR Congress 2016 |
| Document Type(s): Abstract, Poster |
| Countries: France |
C:
Y: |
Clinical practice, Gastrointestinal disorders
2016 |
|
L:
A: |
English
Retrospective database analysis, Survey research |
|
|
| |
| |
| Integrating the Patient Perspective Into Clinical Research Study Designs: Case Studies and Recommendations. |
| Author(s): David Cameron |
| Affiliations(s): QuintilesIMS |
| Publication(s): Journal for Clinical Studies |
| Document Type(s): Article |
| Countries: USA |
C:
Y: |
Clinical practice, Methodology
2016 |
|
L:
A: |
English
|
|
|
| |
| |
| Audit of irreversible monoamine oxidase inhibitor (MAOI) prescribing for depression in current clinical practice using The Health Improvement Network (THIN) UK primary care database |
| Author(s): Nasser A, O’Leary C, Myland M, Sam Waples S & Ansell D |
| Affiliations(s): IMS Health
|
| Publication(s): PRIMM conference, 26th Annual Scientific Meeting, Imperial Hotel, Russell Square, London
|
| Document Type(s): Poster |
| Countries: UK |
| Click here for the abstract |
C:
Y: |
Clinical practice, Health policy, Mental health
2015 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Patterns of systemic lupus erythematosus expression in Europe |
| Author(s): Cervera R1, Doria A2, Amoura Z3, Khamashta M4, Schneider M5, Guillemin F6, Maurel F7, Garofano A7, Roset M8, Perna A9, Murray M10, Schmitt C11, Boucot I12 |
| Affiliations(s): 1. Departmeent of Autoimmune Diseases, Hospital Clinic, Barcelona Spain, 2. Division of Rheumatology, University of Padova, Italy, 3. Internal medecine Department 2, la pitié Salpetrière Hospital, Paris France, 4. Lupus research Unit, The Rayne inistitue Lambeth Wing, St Thomas 'Hospital London, England, 5. Policlinic of Rheumatology, Heinrich-Heine University, Germany, 6. INSERM CIC-EC, CHU Nancy, France, 7. IMS HEOR, Paris La Défense France, 8. IMS HEOR, Barcelona Spain, 9. Immuno Inflammation & infectious diseases Global Franchise, GSK, UK, 10. Access to Medicine Centre of Excellence GSK, UK, 11. Global Health Outcomes GSK, UK, 12. Medical Dpt GSK, Marly-le-Roi France |
| Publication(s): Autoimmunity Reviews - Volume 13, Issue 6, June 2014, Pages 621-629 |
| Document Type(s): Article, Manuscript in preparation |
| Countries: France, Germany, Italy, Spain, UK |
C:
Y: |
Clinical practice, Dermatology, Immunology and Vaccination, Musculoskeletal disease, Neurological disorders
2014 |
|
L:
A: |
English
Epidemiological study, Observational study, Prospective study |
|
|
| |
| |
| Tracking of adverse drug reactions in social media: Current status of requirements, best practices, methods and tools |
| Author(s): Toussi M1, de Moor C1, Nadarajah S2, Breckenridge A3 |
| Affiliations(s): 1 IMS Health, Paris, France 2 IMS Health, US 3 University of Liverpool, UK |
| Publication(s): 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Oct 24-27, 2014, Taipei International Convention Center |
| Document Type(s): Workshop |
| Countries: France, UK |
C:
Y: |
Clinical practice
2014 |
|
L:
A: |
English
Database Study |
|
|
| |
| |
| Understanding patterns of drug utilization studies (DUS) requested by the European Medicines Agency (EMA) |
| Author(s): Schroeder C1, Keja J2, Hughes B2, Ehlken B3, Toussi M3 |
| Affiliations(s): 1 IMS Health, Munich, Germany 2 IMS Health, London, UK 3 IMS Health, Paris, France |
| Publication(s): 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Oct 24-27, 2014, Taipei International Convention Center |
| Document Type(s): Podium presentation |
| Countries: |
C:
Y: |
Clinical practice
2014 |
|
L:
A: |
English
Database Study |
|
|
| |
| |
| Drug utilization in oncology: Current topics and challenges |
| Author(s): Ehlken B1, Keja J1, Kallich J2 |
| Affiliations(s): 1 IMS Health, Munich, Germany 2 Big Health Data, Los Angeles, California, USA |
| Publication(s): AccessPoint, 2014, May; 4(8): 51-55 |
| Document Type(s): Article |
| Countries: |
| Click here for the abstract |
C:
Y: |
Clinical practice, Oncology
2014 |
|
L:
A: |
English
Real World Data |
|
|
| |
| |
| Using data envelopment analysis (DEA) to rank GP's according to their P4P quality and efficiency scores |
| Author(s): Perronnin M, Pichetti S, Sermet C |
| Affiliations(s): Irdes, Paris, France |
| Publication(s): ISPOR 17th Annual European Congress
8-12 November 2014
Amsterdam RAI
Amsterdam, The Netherlands |
| Document Type(s): Poster |
| Countries: France |
| Click here for the abstract |
C:
Y: |
Clinical practice
2014 |
|
L:
A: |
English
|
|
|
| |
| |
| Do quality or efficiency indicators inside French p4p perimeter influence quality or efficiency indicators outside P4P? |
| Author(s): Perronnin M, Pichetti S, Sermet C |
| Affiliations(s): Irdes, Paris, France |
| Publication(s): ISPOR 17th Annual European Congress
8-12 November 2014
Amsterdam RAI
Amsterdam, The Netherlands |
| Document Type(s): Poster |
| Countries: France |
| Click here for the abstract |
C:
Y: |
Clinical practice
2014 |
|
L:
A: |
English
|
|
|
| |
| |
 1 of 4 
|
